[Nosocomial fungal infections, analysis of 149 cases]

Zheng-Yin Liu1, Rui-Yuan Sheng, Xu-Li Li

  • 1Department of Infectious Disease, Peking Union Medical College Hospital, Beijing 100730, China.

Abstract

Insights

Nosocomial fungal infections are increasing, often linked to broad-spectrum antibiotics and chemotherapy. Early diagnosis and treatment are crucial for improving outcomes in these complex cases.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Hospital Epidemiology

Context:

  • Nosocomial fungal infections (NFIs) pose a significant challenge in healthcare settings.
  • A retrospective analysis of 149 patients with NFIs was conducted at PUMC hospital from 1981 to 2001.
  • The study examines the clinical characteristics, diagnostic approaches, therapeutic interventions, and outcomes of these infections.

Purpose:

  • To investigate the clinical manifestations, diagnostic methods, antifungal therapies, and patient outcomes associated with nosocomial fungal infections.
  • To identify trends in the incidence of NFIs over a 20-year period.
  • To highlight the importance of early diagnosis in managing fungal infections.

Summary:

  • Deep mycoses were prevalent in 134 of 149 patients, with underlying conditions including pulmonary diseases, hematological disorders, and HIV/AIDS.
  • Common predisposing factors included prolonged broad-spectrum antibiotic use, chemotherapy, immunosuppressants, and invasive devices.
  • Candida species and Cryptococcus neoformans were primary pathogens; mortality rate was 29.53%, with a notable increase in incidence in recent years.

Impact:

  • The findings underscore a recent rise in fungal infections, correlating with increased use of antibiotics, chemotherapy, and immunosuppressants.
  • Highlights the continued importance of Candida albicans and non-albicans Candida species as key pathogens.
  • Emphasizes the critical need for prompt diagnosis and effective antifungal strategies to mitigate morbidity and mortality.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...